Are patients with bleeding disorders receiving plasma-derived products at increased risk of acquiring COVID-19?
1 Answers
Mednet Member
Pediatric Hematology/Oncology · University of Pittsburgh School of Medicine
No. The current process of manipulation of plasma derived products eliminates SARS-Cov-2. SARS-CoV-2 is a large virus (120 nm diameter) with a lipid envelope. Therefore, it is highly susceptible to processing steps used in processing such as solvent-detergent, low pH incubation, caprylate-pasteuriza...